On the finish of February, Individuals acquired a brand new weapon within the combat in opposition to the coronavirus when the US Meals and Drug Administration (FDA) has granted emergency use authorization for a brand new COVID-19 vaccine, by Johnson & Johnson subsidiary Janssen.
Simply days after this choice, President Joe Biden advert that his administration had helped forge a historic manufacturing collaboration between Johnson & Johnson (J&J) and one among its opponents, Merck. As a part of the settlement, Merck will dedicate two amenities in the US to fabricate the J&J vaccine.
Till then, the federal authorities anticipated to ship sufficient of the 2 beforehand licensed vaccines, by Pfizer-BioNTech and Moderna, to immunize the whole nation by the top of July. With the addition of the Johnson & Johnson vaccine, this schedule has been pushed again. Biden lately stated, “We’re on observe to have sufficient vaccines for each grownup in America by the top of Might.”
William Schaffner, MD, an infectious illness specialist and professor of preventive drugs and well being coverage at Vanderbilt College Faculty of Medication in Nashville, calls the Johnson & Johnson vaccine a game-changer.